Adults who survived HPV-associated cancers appeared at a significant risk for HPV-associated second primary cancers, according a retrospective cohort study.
The Colorado Center for Gynecologic Oncology is excited to share our October Newsletter providing patients with new information, upcoming events and inspiring stories.
What if you could have a skilled medical practitioner devoted to helping you live your best possible life in the midst of or beyond cancer treatment? And what if, instead of having to trek to a doctor’s office, this provider came to you in the comfort of your own home?
A new tool that helps surgeons distinguish healthy tissue from tumor in real-time could change the landscape of surgical ovarian cancer treatment for the better.
Cancer is never an easy foe, but some types are more stubborn than others. Ovarian cancer is one of the hardest to treat… but there are signs of progress.
The Colorado Center for Gynecologic Oncology is excited to share our September Newsletter providing patients with new information, upcoming events and inspiring stories.
September is Gynecologic Cancer Awareness Month (GCAM). The Foundation for Women’s Cancer (FWC) knows the importance of bringing awareness to gynecologic cancers. After creating the month, each year the FWC strives to bring attention and share information about these cancers.
Scientists at Winship Cancer Institute of Emory University have identified an enzyme responsible for making tumors and cancer cell lines resistant to cisplatin, along with an experimental drug that targets that enzyme.
Adults with diabetes have a 10% greater risk for developing any cancer vs. those without diabetes, whereas the disease confers a greater risk for overall and certain site-specific cancers in women vs. men, according to findings from a meta-analysis published in Diabetologia.
While extended adjuvant tamoxifen therapy has been found to improve breast cancer-free survival rates in premenopausal women with estrogen-receptor positive breast cancer, new research suggests that may not be without risk…